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For female sex, overweight, low physical activity, winter season,
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attributed; 2 points for latitude 488N and spring season; 2.5 points for
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Abstract: Vitamin D is essential regarding several health outcomes.
Prevention of insufficiency (25-hydroxyvitamin D concentration 20
ng/mL) generally entails blood testing and/or supplementation, strat-
egies that should target at-risk individuals because blood testing is
costly, and unwarranted supplementation could result in vitamin D
overload with unknown long-term consequences.
Our objective was to develop a simple score (Vitamin D Insuffi-
ciency Prediction score, VDIP) for identifying adults at risk of vitamin
D insufficiency.
Subjects were 1557 non–vitamin D-supplemented middle-aged
adults from the SU.VI.MAX cohort. Scoring points corresponded to
the rounded odds ratio for each individual-level characteristic associated
with vitamin D insufficiency in a multivariable logistic regression
model. Receiver operating characteristic curve (area under curve),
sensitivity, specificity, and positive and negative predictive values were
computed. External validation was performed in an independent cohort
(NutriNet-Sante´, N¼ 781).D, PhD, Khaled E PhD,
ouvier, PhD
obesity and late winter; 3 points for low sun exposure. Points were then
summed up for each participant. The VDIP score had an
AUC¼ 0.70 0.01 (validation: 0.67 0.02). With a score of 7 or more,
70% of the participants were vitamin D-insufficient (80% in those with a
score 9), sensitivity/specificity were 0.67/0.63, and positive and
negative predictive values were 0.70/0.59.
The VDIP score performed well in identifying middle-aged adults at
risk of vitamin D insufficiency (score 7, moderate risk; score9, high
risk), using only simple individual-level characteristics easily assessable in
day-to-day clinical practice. Implementation of this simple and costless
scorecouldthusobviateunwarrantedsupplementationand/orbloodtesting.
(Medicine 95(7):e2783)
Abbreviations: 25OHD = 25-hydroxyvitamin D, AUC = area
under the ROC curve, BMI = body mass index, NPV = negative
predictive value, PPV = positive predictive value, ROC = receiver
operating characteristic, SNP = single nucleotide polymorphism,
SU.VI.MAX = Supple´mentation en VItamines et Mine´raux
AntioXydants, VDIP = vitamin d insufficiency prediction.
INTRODUCTION
V itamin D seems to be the subject of remarkable researchinterest, as shown by the 30,000þ hits on Pubmed regarding
publications from the last decade. This prohormone is provided
by an endogenous synthesis triggered by UVB exposure and, to
a much lesser extent, by a limited number of dietary sources or
supplements. Vitamin D is converted first to 25-hydroxyvitamin
D (25OHD), its main circulating form, and then to 1,25-dihy-
droxyvitamin D, its biologically active form.1,2 It is particularly
known for its involvement in calcium homeostasis and thus its
importance for bone health. However, evidence has emerged
regarding the role of vitamin D in a myriad of physiological
processes unrelated to calcium metabolism, such as immunity,
insulin secretion, neurological function, cardiovascular func-
tion, and cell regulation. Hence, vitamin D could conceivably
play a central role in the prevention of several inflammatory and
chronic diseases, underscoring the importance of maintaining
an adequate vitamin D status.1–3
Vitamin D insufficiency (blood 25OHD concentration
20 ng/mL4) is common in adults worldwide with a prevalence
around 60% in western Europe and 36% in the US.3 In France,5
this prevalence was 42.5% in 2006. It is therefore essential to
identify individuals at risk in order to provide appropriateatment of vitamin D insufficiency gener-
blood testing and/or supplementation.
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Existing recommendations have pointed out that both measures
should target at-risk individuals.6,7 Indeed, vitamin D testing is
certainly not cost-efficient in the general population6–9 and
unwarranted vitamin D supplementation could lead to overload
in some individuals who are not vitamin D deficient, which
itself has unknown long-term consequences.10
In a previous study,11 we tested a wide range of socio-
demographic, lifestyle, anthropometric, and genetic factors in
association with plasma 25OHD concentration and were thus
able to identify determinants of vitamin D insufficiency. Such
knowledge could serve as a basis for the implementation of
strategies to identify individuals at high risk for vitamin
D insufficiency.
Here, our objectives were (1) to develop a simple score that
could be used in daily clinical practice for the detection of
middle-aged adults at risk of vitamin D insufficiency and (2) to
validate this score in an unrelated sample of adults.
SUBJECTS AND METHODS
Study Population
For the development of the Vitamin D Insufficiency Pre-
diction (VDIP) score, we used data from the Supple´mentation
en Vitamines et Mine´raux Antioxydants cohort, a population-
based, double-blind, placebo-controlled, primary prevention
randomized trial (SU.VI.MAX, 1994–2007, www.clinical-
trials.gov, NCT00272428), initially designed to assess the effect
of a 7.5-year daily antioxidant supplementation on the incidence
of cardiovascular diseases and cancer.12 The study was
approved by the Ethics Committee for Studies with Human
Subjects at the Paris-Cochin Hospital (CCPPRB no.1706) and
the ‘‘Commission Nationale de l’Informatique et des Liberte´s’’
(CNIL no.334641). A total of 13,017 participants were enrolled
in 1994 to 1995. All of them provided written informed consent.
Participants were advised not to take any dietary supplement-
ation during the study period. Next, a nested case-control study
was set up to investigate the association between vitamin D
status and cancer risk, including all cases of first incident cancer
diagnosed between 1994 and 2007. Two cancer-free controls
per case were randomly selected and matched on sex, age,
intervention group, and season of blood draw. The present
analysis is based exclusively on the subsample of controls
(n¼ 1850) from this nested case-control study.
For the validation of the VDIP score, we used data
from the NutriNet-Sante´ cohort (approved: IRB Inserm
n80000388FWA00005831 and CNIL n8908450/n8909216), a
large, ongoing, Web-based nutrition-and-health-focused cohort
launched in France in 2009 and open to volunteers aged 18þwith
Internet access.13 Electronic informed consentwas obtained from
each participant (EudraCT no. 2013-000929-31). Of the 158,429
volunteers enrolled to date, 19,600 have provided fasting blood
samples. From that pool, a random sample of 860 individuals was
selected for plasma 25OHD concentration assessment.
Both studies were conducted according to the Declaration
of Helsinki guidelines.
Baseline Data Collection
At enrollment (1994–1995), SU.VI.MAX participants
were invited to complete self-administered questionnaires on
sociodemographics, health/risk behaviors and lifestyle (smok-
ing, medication use, physical activity, etc.) and health status.
Deschasaux et alSubjects self-evaluated their usual level of physical activity as
follows: irregular,<1 h/d walking equivalent or1 h/d walking
equivalent. Height and weight were measured during a baseline
2 | www.md-journal.comclinical examination by study medical staff. A 35 mL venous
blood sample was collected at baseline in vacutainer tubes from
participants who had been fasting for 12 h. All blood draws
occurred between October and May. Blood samples were
centrifuged immediately after blood draw. Plasma aliquots
(preserved in sodium heparin) and buffy-coat fractions were
stored frozen in liquid nitrogen at the central biobank.
In turn, in order to be included in the NutriNet-Sante´ study,
participants fill an initial set of sociodemographic, lifestyle,
health, anthropometrics, and physical activity questionnaires.
Height and weight were self-reported, following the standardized
measurement guidelines provided to the participants. Usual level
of physical activity is assessed via the web version of the
‘‘International Physical Activity Questionnaire’’ (IPAQ)14 and
coded as low, moderate, or high, following the IPAQ guide-
lines.15 Among volunteers who had accepted the clinic visit, a 43
mL fasting (6 h) blood sample was collected using a vacutainer
system. Tubes were fractioned in aliquots containing lithium-
heparin and were stored at 808C at the central biobank.
In both the cohorts, the latitude of each administrative
center (corresponding to the place of residence) was retrieved.
Next, usual sun exposure and Fitzpatrick skin phototype were
obtained through a sun exposure/sun safety questionnaire,
which was previously described in details.16–19 This question-
naire was specifically developed in the context of the SU.VI.-
MAX study and was used again in the NutriNet-Sante´ study.
Participants were asked to provide an estimation of their usual
sun exposure (high, moderate, low, none) and to describe their
skin reaction to a first sun exposure without protection, using
Fitzpatrick classification.
Assessment of Plasma 25OHD Concentration and
Genotyping
In both the cohorts, concentrations of total 25OHD were
measured in baseline plasma samples using the same laboratory.
Measurement relied on Roche Cobas electrochemoluminescent
immunoassay (Roche Diagnostics, Meylan, France), based on
the principle of competitive binding, as previously reported.11,20
The intra-assay coefficient of variation was 4.5% and the inter-
assay coefficient of variation was 6.6%.
Finally, SU.VI.MAX subjects were genotyped for 2 single
nucleotide polymorphisms (SNPs) of the GC gene (rs4588 and
rs7041, both coding for the vitamin D-binding protein) which
have been associated with vitamin D status in previous studies,
including in the SU.VI.MAX cohort.11 As previously reported
in details,11 genetic polymorphisms were assessed by allelic
discrimination using fluorogenic probes and the 5’ nuclease
(TaqMan) assay (Applied Biosystems, Foster City, CA).
Statistical Analysis
From the 1850 SU.VI.MAX participants with available
plasma vitamin D concentration data, the following exclusions
were made prior to analysis: taking medication containing
vitamin D (n¼ 12), presence of epilepsy or renal failure
(n¼ 5) and age <45 years (n¼ 275), leaving 1557 participants
for analyses (see the flow chart in Supplemental Digital Content
1, http://links.lww.com/MD/A691). Participants aged <45
years were excluded because of the differential age at inclusion
between men (45 years) and women (35 years) in the initial
SU.VI.MAX trial.
Medicine  Volume 95, Number 7, February 2016For the development of the VDIP score, a multivariable
unconditional logistic regression model was fit using the
SU.VI.MAX data to model the risk of vitamin D insufficiency
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Associations between Vitamin D Insufficiency and Individual Factors, from Unconditional Logistic Regression Models

,
SU.VI.MAX cohort, France, and NutriNet-Sante´ cohort, France
SU.VI.MAX N¼ 1557 NutriNet-Sante´ N¼ 781
20 vs >20 ng/mLy 20 vs >20 ng/mLy
n OR 95% CI P n OR 95% CI P
Sex <0.0001z 0.4z
Male 833 1 337 1
Female 724 1.81 1.43, 2.29 444 0.88 0.62, 1.24
BMI, kg/m2 0.007z 0.0009z
<18.5 27 1.86 0.77, 4.48 24 0.27 0.08, 0.96
18.5–<25 889 1 529 1
25–<30 537 1.34 1.04, 1.71 182 1.58 1.07, 2.32
30 104 1.99 1.23, 3.22 46 2.72 1.37, 5.39
Physical activity <0.0001 0.3z
Irregular-Low 364 1.74 1.31, 2.32 170 1.33 0.86, 2.06
<1h/d walking equivalent-Moderate 438 1.43 1.10, 1.85 291 1.08 0.74, 1.58
1h/d walking equivalent-High 755 1 182 1
Missing / / 46 0.76 0.42, 1.36
Latitude§ <0.0001 0.0001
Quartile 1 394 1 218 1
Quartile 2 416 1.07 0.78, 1.48 190 1.16 0.75, 1.82
Quartile 3 355 1.79 1.29, 2.48 171 1.41 0.86, 2.29
Quartile 4 392 2.00 1.45, 2.77 202 2.44 1.57, 3.82
Month of blood draw <0.0001z 0.001z
October–November 265 1 129 1
December–January 520 1.56 1.11, 2.18 217 1.91 1.10, 3.34
February–March 604 2.68 1.96, 3.69 341 2.91 1.70, 4.99
April–May 168 2.21 1.42, 3.46 94 2.03 1.04, 3.98
Usual sun exposure <0.0001 0.06z
None-Low 458 3.01 2.02, 4.50 83 2.21 0.98, 4.98
Moderate 931 1.51 1.06, 2.16 380 1.45 0.73, 2.88
High 168 1 54 1
Missing / / 264 1.04 0.50, 2.17
Fitzpatrick phototypejj 0.06 0.003z
I 62 1.41 0.74, 2.67 34 1.11 0.48, 2.58
II 335 1.39 0.97, 1.97 166 1.70 1.03, 2.80
III 877 1.21 0.91, 1.62 286 1.12 0.71, 1.76
IV 283 1 149 1
V / / 38 5.40 2.32, 12.6
VI / / 25 1.24 0.49, 3.17
Missing / / 83 1.56 0.80, 3.03
BMI¼ body mass index.
Multivariable unconditional logistic regression models were adjusted for age (<40 y/40–44y/45–49 y/50–54 y/55–65 y) and included all the
individual factors presented in the table (sex, body mass index, physical activity, latitude, month of blood draw, usual sun exposure, and Fitzpatrick
phototype).
yNumber of subjects with 25OHD concentration 20 ng/mL/>20 ng/mL in SU.VI.MAX: 888/669 and in NutriNet-Sante´: 319/462.
zP nontrend.
§ Cut offs for quartiles of latitude were 45.34/48/48.48 in SU.VI.MAX and 43.37/45.46/48.52 in NutriNet-Sante´.
: bu
Medicine  Volume 95, Number 7, February 2016 Vitamin D Insufficiency Prediction Score(plasma concentration 20 ng/mL). The model was age-
adjusted and included sex, body mass index, physical activity,
residential latitude, month of blood draw, self-estimated usual
sun exposure, and Fitzpatrick skin phototype. To build the
VDIP score, points were assigned to each characteristic associ-
jj I: always burns easily, never tans; II: burns easily, tans minimally; III
rarely, tans profusely; VI: never burns, deep pigmentation.ated with vitamin D insufficiency using the odds ratio (OR)
value rounded to the closest 0.5 to facilitate computation.
Attributed points were then summed up for each participant.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.A higher score thus reflected higher risk of vitamin D insuffi-
ciency. Sensitivity analyses were performed following the
introduction of dietary intakes of vitamin D, and of the 2 SNPs
of the GC gene in the scoring system, and following the
exclusion of participants diagnosed with a cardiovascular dis-
rns moderately, tans gradually; IV: burns minimally, tans well; V: burnsease or diabetes at baseline.
To perform an external validation of the obtained score, an
independent sub-sample of the NutriNet-Sante´ study was
www.md-journal.com | 3
TABLE 2. Score Loading: Attribution of Points for Each
Selected Individual Characteristic

Characteristics Points
Sex
Male 0
Female 1.5
Weight status; BMI, kg/m2
<25 0
between 25 and 30 1.5
30 2.5
Physical activity
Irregular 1.5
<1h/d walking equivalent 1.5
1h/d walking equivalent 0
Residential latitude
<488N (in France: South of a line 0
Medicine  Volume 95, Number 7, February 2016selected as follows: from the 860 participants with available
plasma vitamin D concentration, participants were excluded for
taking vitamin D supplementation (n¼ 79), thus leaving data
from 781 participants available for analyses (see the flow chart
in Supplemental Digital Content 1). The same multivariable
unconditional logistic regression model was fit in that sample.
If <5% of data were missing, they were replaced by the
mode value of the respective variable. If >5% of data were
missing, a ‘‘missing category’’ was introduced into the model.
In both samples, receiver operating characteristic (ROC)
curves were drawn (sensitivity vs 1-specificify) from a logistic
regressionmodel of vitaminD insufficiency,with theVDIP score
modeled as the explanatory variable. Sensitivity, specificity, and
positive and negative predictive values (PPV and NPV) were
calculated for each value of the score and the area under the ROC
curve (AUC) was assessed. The AUC represents the ability of the
test to measure reality, an ideal test having an AUC of 1. In our
study, the AUC shows the ability of the score to accurately
identify people with actual vitamin D insufficiency.
Deschasaux et alfrom mid-Brittany to mid-Alsace)
488N (in France: North of a line
from mid-Brittany to mid-Alsace)
2
Season
June–November 0
December–January 1.5
February–March 2.5
April–May 2
Usual sun exposure
Low/very low 3
Moderate 1.5
High 0
Fitzpatrick phototype
I: always burns easily, never tans 1.5
II: burns easily, tans minimally 1.5
III: burns moderately, tans gradually 0
IV: burns minimally, tans well 0
V: burns rarely, tans profuselyy 1.5
VI: never burns, deep pigmentationy 1.5
Totalz
BMI¼ body mass index.
The individual characteristics with points >0 were the ones for
which an increased risk of vitamin D insufficiency was observed in the
SU.VI.MAX logistic regression model (Table 1). Points were attributed
according to the OR value in the SU.VI.MAX logistic regression model
(Table 1) rounded to the closest 0.5 to facilitate score computation. An
additional 0.5 was given for the ‘‘obese’’ characteristic because obesity
is a major determinant of vitamin D status.
yFitzpatrick phototypes V and VI were not represented in the
SU.VI.MAX population. We extrapolated the points given to the 2
fairest phototypes (I, II) to the 2 darkest (V, VI) for validation in the
NutriNet-Sante´ cohort in which these phototypes were represented.SAS software version 9.3 was used for the analyses (SAS
Institute, Cary, NC). All statistical tests were 2-sided and
P< 0.05 was considered significant.
RESULTS
Mean 25OHD concentrations were 20.2 10.4 ng/mL in
our SU.VI.MAX analysis sample (N¼ 1557), and 24.1 11.7
ng/mL in our NutriNet-Sante´ validation sample (N¼ 781).
More than half (57.0%) of the SU.VI.MAX sample had
25OHD concentration 20 ng/mL (40.8% in the NutriNet-
Sante´ validation sample).
A description of the 2 study populations and results of the
logistic regression models are presented in Table 1. As
expected,11 vitamin D insufficiency in the SU.VI.MAX cohort
(median age at baseline¼ 53 years) was associated with female
sex, being overweight or obese, practicing physical activity
irregularly or 1 h/d walking equivalent, living at Northern
latitudes, blood draw occurring in winter/early spring, having
low or moderate usual sun exposure, and having a very fair skin
(Fitzpatrick phototype I or II). In NutriNet-Sante´ (median age at
baseline ¼ 47 years), the same characteristics were associated
with vitamin D insufficiency (also including the darkest Fitz-
patrick phototypes), except for physical activity and sex. These
results were similar when excluding subjects with missing data
(N¼ 470).
Next, a scoring system was developed from the logistic
regression results obtained in the SU.VI.MAX sample
(Table 2). Points were attributed to the characteristics associ-
ated with vitamin D insufficiency (ORs rounded to the closest
0.5, except for obesity, for which an additional 0.5 was
assigned, given that obesity is recognized as a major determi-
nant of vitamin D insufficiency).21 As noted above, Fitzpatrick
phototypes V and VI (dark skin color) were not represented in
the SU.VI.MAX population. Hence, we extrapolated the points
given to the 2 fairest phototypes (Fitzpatrick types I and II) to
the 2 darkest phototypes (Fitzpatrick types V and VI) for
validation purposes in the NutriNet-Sante´ sample, in which
these phototypes were represented. In Supplemental Digital
Content 2, http://links.lww.com/MD/A691, we present a simple
checklist that could be completed in 5 minutes and can be used
in day-to-day practice to gather personal information needed for
computing the VDIP score.
In turn, Table 3 provides the distribution of the VDIP score
in the SU.VI.MAX sample with the corresponding sensitivity,
4 | www.md-journal.comspecificity, PPV, and NPV. The median score was 7.0 (min: 0,
Q1: 5.5, Q3: 9.0, max: 14.0). A score7 was observed in 54.3%
of the sample, with the following properties: sensitivity¼ 0.67,
specificity¼ 0.63, PPV¼ 0.70, and NPV¼ 0.59. In total, for
8.9% of the participants with a score7, 25OHD concentration
was>30 ng/mL, and it was>40 ng/mL for 1.8%. Among those
with a score 9, the corresponding proportions were 4.3% and
zFinal score is comprised between 0 and 14.5.1.0%. The ROC curve associated with the score is presented in
Figure 1a. The AUC was 0.70 0.01. Similar results were
observed after the exclusion of participants who declared a
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Sensitivity and Specificity for the Detection of Vitamin D Insufficiency (25OHD20 ng/mL) for Each Value of the Score,
N¼1557, SU.VI.MAX cohort, France
Score N % Sensitivity Specificity True positives False positives PPV

NPVy
14 1 0.06 0.00 1.00 0 1 / 0.43
13.5 7 0.4 0.01 1.00 5 2 0.71 0.43
13 13 0.8 0.01 1.00 10 3 0.77 0.43
12.5 24 1.6 0.02 0.99 19 5 0.79 0.43
12 57 3.7 0.06 0.99 49 8 0.86 0.44
11.5 79 5.1 0.08 0.99 69 10 0.87 0.45
11 111 7.1 0.10 0.97 93 18 0.84 0.45
10.5 181 11.6 0.17 0.95 148 33 0.82 0.46
10 237 15.2 0.22 0.94 195 42 0.82 0.48
9.5 290 18.6 0.27 0.92 236 54 0.81 0.49
9 396 25.4 0.36 0.88 316 80 0.80 0.51
8.5 492 31.6 0.43 0.84 385 107 0.78 0.53
8 569 36.6 0.49 0.80 433 136 0.76 0.54
7.5 725 46.6 0.59 0.69 520 205 0.72 0.56
7 845 54.3 0.67 0.63 595 250 0.70 0.59
6.5 926 59.5 0.72 0.57 635 291 0.69 0.60
6 1086 69.8 0.81 0.45 719 367 0.66 0.64
5.5 1178 75.7 0.86 0.38 765 413 0.65 0.68
5 1226 78.8 0.89 0.34 787 439 0.64 0.69
4.5 1360 87.4 0.94 0.22 835 525 0.61 0.73
4 1387 89.1 0.95 0.19 845 542 0.61 0.75
3.5 1410 90.6 0.96 0.17 854 556 0.61 0.77
3 1514 97.3 0.99 0.05 880 634 0.58 0.81
2.5 1520 97.7 0.99 0.04 880 640 0.58 0.78
2 1522 97.8 0.99 0.04 881 641 0.58 0.80
1.5 1555 99.9 1.00 0.00 888 667 0.57 1.00
0 1557 100 1.00 0.00 888 669 0.57 /
PPV¼ positive predictive value, NPV¼ negative predictive value.

Positive predictive value ¼ True positives individuals with a score cut off and 25OHD20ng=mLð ÞTotal positives individuals with a score cut offð Þ , which corresponds to the proportion of partici-
re
ut o
th a
belo
Medicine  Volume 95, Number 7, February 2016 Vitamin D Insufficiency Prediction Scorecardiovascular disease or diabetes at baseline (N¼ 1476,
AUC¼ 0.70 0.01). Likewise, similar AUC were observed
with a modified VDIP score that included the SNPs GC
rs4588 (0 point for the genotype GG, 1.5 for GT and 2 for
TT) and rs7041 (0 point for the genotype CC, 1.5 for AC and
AA) (AUC¼ 0.71 0.01) or with a modified VDIP score that
included dietary intake of vitamin D (0 point for quartiles 3 and
4, 1.5 for quartiles 1 and 2) (AUC¼ 0.70 0.01) [data not
tabulated].
In the NutriNet-Sante´ validation sample (Table 4), the
median VDIP score was 6.0 (min: 0, Q1: 4.5, Q3: 8.0, max:
14.5). A score7 was observed in 45.2% of the sample, with the
following properties: sensitivity¼ 0.61, specificity¼ 0.66,
PPV¼ 0.55, and NPV¼ 0.71. In total, for 19.3% of subjects
with a score 7, 25OHD concentration was >30 ng/mL, and it
was >40 ng/mL for 7.6%. Among those with a VDIP score 9,
pants with actual vitamin D insufficiency among individuals with a sco
yNegative predictive value ¼ True negatives individuals with a score< cð
Total negatives individuals wið
pants without vitamin D insufficiency among individuals with a scorethe corresponding proportions were 17.9% and 6.4%. The ROC
curve associated with the score is presented in Figure 1b. The
AUC was 0.67 0.02.DISCUSSION
In this study, a simple scoring system based on easy-to-
assess individual characteristics was developed in a population
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.of nonsupplemented middle-aged French adults to predict
vitamin D insufficiency. The VDIP score computation uses
information on individual characteristics associated with vita-
min D status (sex, BMI, physical activity, residential latitude,
season, usual sun exposure, and Fitzpatrick skin phototype) that
could feasibly be gathered in clinical practice using a 5-minute
checklist (Supplemental Digital Content 2). The VDIP score
performed well, with an AUC of 0.70 0.01 (0.67 0.02 in the
validation sample). It thus constitutes a useful tool to be
integrated in clinical practice to obviate unnecessary supple-
mentation and blood testing.
As indicated by the PPV, 70% of the participants with a
score7 were vitamin D-insufficient (80% in those with a score
9). Any patient with a VDIP score7 to<9 could be regarded
as moderately at risk of vitamin D insufficiency and any patient
with a score 9 could be regarded as being at high risk.
In practice, if a patient has a VDIP score higher than a
selected cut off, a vitamin D supplementation could be recom-
mended. The choice of the cut off depends on the context and on
the clinical and/or public health objectives, and should undergo
a validation in clinical laboratories. This is why all character-
above the chosen cut off.
ff and 25OHD> 20ng=mLÞ
score< cut offÞ , which corresponds to the proportion of partici-
w the chosen cut off.istics (sensitivity, specificity, PPV, and NPV) for all cut offs are
provided in Tables 3 and 4. A cut-off score of 7 represents a
balance between relatively high sensitivity and high specificity.
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FIGURE 1. ROC curves for the VDIP score in the detection of vitamin D insufficiency (25-hydroxyvitamin D 20 ng/mL), (A) SU.VI.MAX
cohort (N¼1557), (B) NutriNet-Sante´ cohort (N¼781), France. The ROC curve of the VDIP score (solid line) draws the sensitivity vs 1
minus the specificity. For each value of the VDIP score, the sensitivity is the probability to accurately classify a person with vitamin D
insufficiency (true positive) and the specificity is the probability to accurately classify a person who does not have a vitamin D insufficiency
(true negative). Conversely, 1 minus the specificity is the probability for a person to be classified as ‘‘vitamin D insufficient’’ while this
person does not have vitamin D insufficiency (false positive). For instance, in (A), a VDIP score7 corresponded to a sensitivity¼0.67, and
a specificity¼0.63. The first bisector (dotted line) represents the ROC curve of a test that would be no better than random. The more a
ROC curve is away from the first bisector toward the upper left corner, the better the screening ability of the test is. The AUC represents the
ability of the score to accurately identify people with actual vitamin D insufficiency. AUC¼ area under curve, ROC¼ receiver operating
characteristic, VDIP¼Vitamin D Insufficiency Prediction score.
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TABLE 4. Sensitivity and Specificity for the Detection of Vitamin D Insufficiency (25OHD20 ng/mL) for Each Value of the Score,
N¼781, NutriNet-Sante´ cohort, France
Score N % Sensitivity Specificity True positives False positives PPV

NPVy
¼14.5 1 0.1 0.00 1.00 0 1 0.00 0.59
13 2 0.3 0.00 1.00 1 1 0.50 0.59
12.5 3 0.4 0.01 1.00 2 1 0.67 0.59
12 12 1.5 0.03 0.99 8 4 0.67 0.60
11.5 22 2.8 0.05 0.99 16 6 0.73 0.60
11 27 3.5 0.07 0.99 21 6 0.78 0.60
10.5 53 6.8 0.12 0.97 38 15 0.72 0.61
10 76 9.7 0.17 0.95 54 22 0.71 0.62
9.5 88 11.3 0.19 0.94 62 26 0.70 0.63
9 140 17.9 0.27 0.88 85 55 0.61 0.63
8.5 181 23.2 0.33 0.83 104 77 0.57 0.64
8 208 26.6 0.38 0.81 121 87 0.58 0.65
7.5 288 36.9 0.51 0.73 162 126 0.56 0.68
7 353 45.2 0.61 0.66 194 159 0.55 0.71
6.5 382 48.9 0.64 0.61 204 178 0.53 0.71
6 470 60.2 0.74 0.50 237 233 0.50 0.74
5.5 532 68.1 0.80 0.40 256 276 0.48 0.75
5 558 71.5 0.82 0.36 261 297 0.47 0.74
4.5 631 80.8 0.88 0.24 280 351 0.44 0.74
4 667 85.4 0.93 0.20 296 371 0.44 0.80
3.5 673 86.2 0.93 0.19 297 376 0.44 0.80
3 729 93.3 0.98 0.10 312 417 0.43 0.87
2.5 737 94.4 0.98 0.08 314 423 0.43 0.89
2 741 94.9 0.99 0.08 315 426 0.43 0.90
1.5 774 99.1 1.00 0.01 318 456 0.41 0.86
0 781 100 1.00 0.00 319 462 0.41 /
PPV¼ positive predictive value, NPV¼ negative predictive value.

Positive predictive value ¼ True positives individuals with a score cut off and 25OHD20ng=mLð ÞTotal positives individuals with a score cut offð Þ , which corresponds to the proportion of partici-
re
ut o
ith a
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Medicine  Volume 95, Number 7, February 2016 Vitamin D Insufficiency Prediction ScoreIf the objective is to detect a maximum of patients with vitamin
D insufficiency (increased sensitivity), then lower cut-off scores
such as 5.5 or 6 could be selected. However, this strategy would
also lead to a higher proportion of people wrongly classified as
vitamin D insufficient (false positives) because of a decreased
specificity. In contrast, if the objective is to minimize the
proportion of wrongly classified people (increased specificity),
then higher cut-off scores, such as 9, could be selected. How-
ever, this strategy would also lead to a decreased sensitivity and
thus a decreased number of detected people.
Among those who would be identified as vitamin D-
insufficient based on the score, a small yet nonnegligible
proportion (especially in the validation sample) had a
25OHD concentration >40 ng/mL. Cautious dosing of vitamin
D supplements may thus be advised, in line with the recom-
mendations made by the Institute of Medicine.4,10
Admittedly, a few studies have already advanced scoring
guidelines to predict vitamin D status, either in order to identify
a proxy for blood 25OHD concentration in large cohorts,22 or
with the objective to detect at-risk individuals in clinical
practice.23–27 However, most of these investigations were either
based on relatively restricted samples,24,26,27 or were focused on
pants with actual vitamin D insufficiency among individuals with a sco
yNegative predictive value ¼ True negatives individuals with a score< cðTotal negatives individuals wð
pants without vitamin D insufficiency among individuals with a scorespecific population subgroups,24 or included a very limited
number of individual characteristics,23,27 or included charac-
teristics that are practically impossible to assess in a quick and
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.easy fashion (as dietary vitamin D intake and precise UV
exposure),22,26 or provided complex, hard-to-interpret coeffi-
cients,22 or did not perform external validation in an indepen-
dent sample.23,24,26,27 Sohl et al25 were the first who
successfully developed models to predict vitamin D deficiency
in the general elderly European population. This study focused
on older subjects (mean age¼ 76 years) and thus included
frailty indicators associated with cognitive and physical decline
in the elderly. In contrast, our VDIP score is designed to be
implemented in a non–vitamin D-supplemented noninstitutio-
nalized middle-aged adult population.
These scores had similar discrimination performances
when predicting vitamin D insufficiency (25OHD 20 ng/
mL) compared to ours: Nabak et al24 observed a sensitivity/
specificity of 89%/35% at their chosen cut off; Lopes et al23
observed an AUC of 0.68; Tran et al26 observed an AUC of
0.73; Bolek-Berquist et al27 observed a sensitivity/specificity of
79%/78% at their chosen cut off (detection of people with
25OHD<16 ng/mL); and Sohl et al25 observed an AUC of 0.78
(0.71 in the external validation).
Our analyses showed that inclusion of characteristics that
would require a time-consuming, costly and/or invasive assess-
above the chosen cut off.
ff and 25OHD> 20 ng=mLÞ
score< cut offÞ , which corresponds to the proportion of partici-
w the chosen cut off.ment, such as dietary vitamin D intake orGC rs4588 and rs7041
SNPs, did not improve substantially the discriminatory per-
formance of the score.
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Our study had several strengths such as a large sample size
and an independent cohort available for validation purposes.
The score we developed accounts for a relatively small number
of individual-level parameters that could be easily assessed and
computed with a simple checklist. This scoring system is
therefore a noninvasive method for a quick and efficient
assessment of the likelihood of vitamin D insufficiency.
However, some limitations should be acknowledged. First,
in both the cohorts, subjects were volunteers participating in
long-term studies on nutrition and health and thus may not be
representative of the French population. Also, the large majority
of the participants were non-Hispanic whites. In SU.VI.MAX,
people < 45 years or those with darker skin tones were not
represented, even though these categories were included in the
NutriNet-Sante´ cohort. Next, we did not have information on
individual clothing habits. Overall, the use of the VDIP score in
other Western nonsupplemented population requires caution
given that the modeled latitudes are in a relatively narrow range,
and also that dietary vitamin D intake in France is rather limited
and thus, is not a major determinant of vitamin D status.11 This
may be different in other countries with higher dietary vitamin
D intake. Second, our score was built in a non–vitamin D-
supplemented population. Indeed, spontaneous dietary supple-
ment use was not allowed in the SU.VI.MAX trial and we
excluded participants who declared taking drugs containing
vitamin D in our analyses. In the NutriNet-Sante´ sample, we
excluded participants using vitamin D supplements or drugs.
Supplementation is supposed to have a great influence on
vitamin D status. However, the primary goal of our study
was to provide a tool to detect vitamin D insufficiency prior
to medical decision (ie, prior to supplementation). Third, in the
NutriNet-Sante´ study, there were some missing data on covari-
ates, especially for sun exposure, Fitzpatrick phototype, and
physical activity. A missing class was entered into the logistic
regression model and individuals were kept in the sample for
score computation, with no point attributed for the missing
characteristics. This may have induced some misclassification
and thus decreased the performance of the score. Exclusion of
participants with missing data provided similar results but
induced loss of statistical power in the analyses. In addition,
weight and height were self-reported in the NutriNet-Sante´
cohort, thus classification bias could not be excluded. However,
in a previous validation study, we showed that self-reported
weight and height data from the NutriNet-Sante´ study were
valid and strongly correlated with anthropometric data
measured by study staff.28 Fourth, although main analyses
excluded participants with epilepsy and renal failure at baseline
and sensitivity analyses excluded participants with cardiovas-
cular diseases or diabetes at baseline, analyses that excluded
participants with other autoimmune diseases at baseline could
not be performed since this information was not validated in the
present study. Finally, vitamin D status also is likely determined
by other complex biological parameters beyond the simple
individual characteristics included in the VDIP score, which
could explain the remaining variability.
The simple VDIP score, developed and externally vali-
dated in this study, performed well in identifying middle-aged
nonsupplemented adults at risk of vitamin D insufficiency who
might benefit from vitamin D supplementation. The score was
designed to be used in daily clinical practice, given that it is
based on a quick and simple checklist that could be adminis-
Deschasaux et altered in physician waiting rooms. Computation of the
VDIP score is easy and costless, yet its potential as a primary
screening tool for vitamin D insufficiency should not be
8 | www.md-journal.comunderestimated. This score could help to better target at-risk
individuals and thus to avoid unnecessary systematic supple-
mentation or blood testing.
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